T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities
Advanced Science · 2026-06 · 13 (35)
DOI: 10.1002/advs.202520634 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 12.01.2026. Verfasst von Yang Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chinese Medicine and State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Macau,…. Hauptthemen laut MEDLINE: T-Cell Exhaustion, Neoplasms, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 590 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Shandong Taishan Scholars Specially Invited Expert Talent Project.
Abstract (Originalsprache)
T cell exhaustion represents a pivotal mechanism of immune escape in cancer, with its inherent heterogeneity and dynamic plasticity being key determinants of the variable responses and resistance to immune checkpoint inhibitors (ICIs). This review comprehensively delineates the multifaceted heterogeneity of exhausted T (T EX ) cells, tracing their developmental trajectory from precursor exhausted T (T PEX ) cells to terminally differentiated exhausted T (T EX ‐term ) cells. We highlight both distinct and shared exhaustion features across diverse cancer types and spatial niches within the tumor microenvironment. Furthermore, we examine the multi‐layer biomarkers that drive and define this state, including characteristic surface inhibitory receptors, core transcription factors, and metabolism‐associated molecules. Grounded in this mechanistic understanding, we discuss emerging therapeutic strategies aimed at reversing T cell exhaustion. These range from the optimized application of ICIs and rational combination therapies involving epigenetic or metabolic interventions, to next‐generation engineered cell therapies such as chimeric antigen receptor T cell (CAR‐T), T cell receptor‐engineered T cell (TCR‐T), and tumor‐infiltrating lymphocytes (TILs), alongside emerging modalities including oncolytic viruses and bispecific antibodies. Finally, we discuss prevailing challenges and future directions, emphasizing that deciphering the heterogeneous landscape of T EX cells, identifying precise biomarkers, and developing temporally controlled combination regimens are imperative to effectively reverse T cell exhaustion and broaden the therapeutic efficacy of cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chinese Medicine and State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Macau, China.
- School of Public Health, Shandong Second Medical University, Weifang, China.
- College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Antitumor Omics Laboratory of Traditional Chinese Medicine, Weifang Traditional Chinese Hospital, Weifang, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome/Chinese Medicine Guangdong Laboratory, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese M…
- Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Zhejiang, China.
ORCID-Profile: Changgang Sun
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
- Shandong Taishan Scholars Specially Invited Expert Talent Project
- National Administration of Traditional Chinese Medicine Science and Technology Department Science and Technology Joint Construction Project
- Shandong Province Natural Science Foundation Innovation and Development Joint Fund
- China Association of Chinese Medicine Young Scientists Program for Research Integrity
Zitieren
APA
Yu, Y., Yao, X., Wang, Q., Yang, M., Li, R., Qin, J., Zhuang, J., & Sun, C. (2026). T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities. Advanced Science, 13(35). https://doi.org/10.1002/advs.202520634
Vancouver
Yu Y, Yao X, Wang Q, Yang M, Li R, Qin J, et al. T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities. Advanced Science. 2026;13(35). doi:10.1002/advs.202520634
BibTeX
@article{Yu2026,
author = {Yu, Yang and Yao, Xiaoyu and Wang, Qingyang and Yang, Mengrui and Li, Runze and Qin, Jiangjiang and Zhuang, Jing and Sun, Changgang},
title = {T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {35},
doi = {10.1002/advs.202520634}
}
EUVIMED